News FocusClinical Research

Advocating, the Clinical Way

See allHide authors and affiliations

Science  13 May 2005:
Vol. 308, Issue 5724, pp. 940-942
DOI: 10.1126/science.308.5724.940

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

As advocacy groups in the orphan disease world plunge into clinical trials, they're faced with a delicate balancing act.